The Carcinoma–Stromal Ratio of Colon Carcinoma Is an Independent Factor for Survival Compared to Lymph Node Status and Tumor Stage | Zendy

Wilma E. Mesker | Zendy; Jan M. C. Junggeburt | Zendy; Károly Szuhai | Zendy; Pieter de Heer | Zendy; Hans Morreau | Zendy; Hans J. Tanke | Zendy; Rob A.�E.�M. Tollenaar | Zendy

Open Access

The Carcinoma–Stromal Ratio of Colon Carcinoma Is an Independent Factor for Survival Compared to Lymph Node Status and Tumor Stage

Author(s) -

Wilma E. Mesker,

Jan M. C. Junggeburt,

Károly Szuhai,

Pieter de Heer,

Hans Morreau,

Hans J. Tanke,

Rob A.�E.�M. Tollenaar

Publication year - 2007

Publication title -

analytical cellular pathology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.576

H-Index - 24

eISSN - 2210-7185

pISSN - 2210-7177

DOI - 10.1155/2007/175276

Subject(s) - stage (stratigraphy) , carcinoma , lymph node , oncology , medicine , stromal cell , biology , paleontology

Tumor staging insufficiently discriminates between colon cancer patients with poor and better prognosis. We have evaluated, for the primary tumor, if the carcinoma-percentage (CP), as a derivative from the carcinoma-stromal ratio, can be applied as a candidate marker to identify patients for adjuvant therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research